Approved: First Biosimilar to Treat Anemia
The US Food and Drug Administration (FDA) has approved a new medication to treat anemia.
A Change in REMS Requirements
The US Food and Drug Administration (FDA) has lifted the Risk Evaluation and Mitigation Strategy (REMS) requirements for certain medications used to treat anemia.
An Extra Benefit for Sickle Cell Rx
A drug commonly used to treat sickle cell disease (SCD) may wind up helping patients in more ways than one.
FDA OKs Hyperkalemia Rx
A new medication could help patients with a serious condition called hyperkalemia.
Blocked Blood Flow in Kidney Disease
If your kidneys are damaged, you may start to have health problems in other parts of your body. As rates of kidney disease rise, researchers want to know what these health problems may be.
Blood Problem Linked to Transplant Loss
Kidney transplants can save the lives of children with kidney failure. But not all children's bodies accept the new kidneys. After transplant surgery, the goal for doctors is to keep the new organ in good running order.
FDA Green Lights Anemia Drug Omontys
U.S. Food and Drug Administration officials have approved Omontys ( peginesatide ), a drug administered through monthly injections to treat anemia in patients with chronic kidney disease.
FDA Approves Soliris For Rare Pediatric Blood Disorder
The U.S. Food and Drug Administration today approved Soliris ( eculizumab ) to treat patients with atypical hemolytic uremic syndrome ( aHUS ), a rare and chronic blood disease that can lead to kidney (renal) failure and is also associated with increased risk of death and stroke.
Low Blood Pressure During Dialysis May Lead to Clots
It's been known that low blood pressure while undergoing kidney dialysis is linked to some nasty side effects. Now the risk of blood clots has been added to that expanding list.
Blood Cleaning Provides New Transplant Options
Finding a transplant match is no easy task. In addition to organ size and donor age, blood types must also match. A novel procedure may make the blood type issue a thing of the past.